USANA Health Sciences, Inc. (USNA) Investor Relations Documents

USANA Health Sciences, Inc. (USNA) investor relations documents from the company's IR site: 7 presentations, 22 press releases; latest deck 2026-05-26. Read in-app with summaries. First-party data.

Investor Presentation Q1 2026: USANA Health Sciences May 2026 investor overview outlines a strategic pivot to an omnichannel wellness platform, projecting FY 2026 revenue of $925M to $1.0B driven by Hiya and

Investor relations documents — source: company IR site

Published	Type	Document
2026-08-04	Press release	Management Commentary
	Press release	USANA Health Sciences Reports Second Quarter 2026 Results
	Press release	USANA Schedules Second Quarter 2026 Earnings Release and Conference Call
2026-05-26	Presentation	Investor Presentation Q1 2026
2026-05-05	Press release	PDF
2026-05-05	Earnings deck	Management Commentary
	Press release	USANA Schedules First Quarter 2026 Earnings Release and Conference Call
	Press release	USANA Health Sciences Reports First Quarter 2026 Results
2026-02-17	Earnings deck	Management Commentary
	Press release	USANA Health Sciences Reports Third Quarter 2025 Results and Updates Full-Year Outlook
	Press release	USANA Updates the Timing of the Release of Third Quarter 2025 Earnings Release and Conference Call
	Press release	USANA Schedules Second Quarter 2025 Earnings Release and Conference Call
	Press release	USANA Schedules First Quarter 2025 Earnings Release and Conference Call
2024-02-06	Earnings deck	Management Commentary
2023-10-24	Earnings deck	Management Commentary
2023-07-25	Earnings deck	Management Commentary
2023-04-25	Earnings deck	Management Commentary
	Press release	USANA Health Sciences Reports Second Quarter 2025 Results and Reiterates Full-Year Outlook
	Press release	USANA Health Sciences Reports First Quarter 2025 Results and Reiterates Full-Year Outlook
	Press release	USANA Health Sciences Provides Preliminary Fiscal Year 2025 Net Sales and Issues Initial Fiscal Year 2026 Net Sales Outl
	Press release	USANA Health Sciences Reports Second Quarter Net Sales of $238 Million and Diluted EPS of $0.89
	Press release	USANA Health Sciences Reports First Quarter Net Sales of $248 Million and Diluted EPS of $0.95
	Press release	USANA Health Sciences Reports Fourth Quarter and Fiscal Year 2022 Results
	Press release	USANA Health Sciences Reports Fourth Quarter and Fiscal Year 2023 Results
	Press release	USANA Health Sciences Reports Fourth Quarter and Full Year 2024 Results and Provides Fiscal Year 2025 Outlook
	Press release	USANA Health Sciences Reports Third Quarter 2024 Results
	Press release	USANA Health Sciences Reports Second Quarter 2024 Results
	Press release	USANA Health Sciences Reports First Quarter 2024 Results
	Press release	USANA Health Sciences Reports Fourth Quarter and Full Year 2025 Results and Provides Fiscal Year 2026 Outlook

USNA overview · USNA earnings · USNA financials · USNA KPIs · USNA ownership · USNA peers · USNA filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.